| Original language | English |
|---|---|
| Pages (from-to) | 1443-1444 |
| Number of pages | 2 |
| Journal | Annals of Oncology |
| Volume | 15 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sep 2004 |
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Topotecan versus paclitaxel in second-line therapy : A lost opportunity for quality-of-life evaluation? (multiple letter) [1]. / Apolone, G.; Buda, A.; Ross, Graham A.; Kettels, J. A.
In: Annals of Oncology, Vol. 15, No. 9, 09.2004, p. 1443-1444.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Topotecan versus paclitaxel in second-line therapy
T2 - A lost opportunity for quality-of-life evaluation? (multiple letter) [1]
AU - Apolone, G.
AU - Buda, A.
AU - Ross, Graham A.
AU - Kettels, J. A.
PY - 2004/9
Y1 - 2004/9
UR - http://www.scopus.com/inward/record.url?scp=4644364705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4644364705&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdh357
DO - 10.1093/annonc/mdh357
M3 - Article
C2 - 15319253
AN - SCOPUS:4644364705
VL - 15
SP - 1443
EP - 1444
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 9
ER -